Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein-Barr virus infection

American Journal of Hematology

Volumn 82, Issue 12, 2007, Pages 1106-1109

  Miyazaki, Takuya ^a   Fujimaki, Katsumichi ^a   Shirasugi, Yukari ^b   Yoshiba, Fumiaki ^b   Ohsaka, Manabu ^c   Miyazaki, Koji ^c   Yamazaki, Etsuko ^d   Sakai, Rika ^d   Tamaru, Jun Ichi ^e   Kishi, Kenji ^b   Kanamori, Heiwa ^a   Higashihara, Masaaki ^c   Hotta, Tomomitsu ^b   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Fujisawa City Hospital   (Japan)

^e Department of Gastroenterology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BLEOMYCIN; BUCILLAMINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GOLD; METHOTREXATE; MIZORIBINE; PREDNISOLONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTHRITIS, RHEUMATOID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 36749016158     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21003     Document Type: Article

References (36)

1. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-1751.
2. Callan MFC. Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol 2004;16:399-405.
3. Balandraud N, Roudier J, Roudier C, Pharm D. What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis antagonism in rheumatoid arthritis? Semin Arthritis Rheum 2005;34:31-33.
4. Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 2004;16:254-261.
5. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J, the investigators of the Club Rheumatismes et Inflammation. Lymphoma in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France. Blood 2002;99:3909-3915.
6. Kamel OW, van de Rijn M, Weiss LM, et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328:1317-1321.
7. Salloum E, Cooper DJ, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic disease. J Clin Oncol 1996;14:1943-1949.
8. Baeklund E, Sundström C, Ekbom A, et al. Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48:1543-1550.
9. Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjogren's syndrome: Case series. J Rheumatol 2001;28:47-53.
10. Ferraccioli GF, Casatta L, Bartoli E, et al. Epstein-Barr virus associated Hodgkin, lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 1995;38:867-868.
11. Lioté F, Pertuiset É, Cochand-Priollet B, et al. Methotrexate related B lymphoproliferative disease in a patients with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 1995;22:1174-1178.
12. Kamel OW, van de Rijn M, Hanasono MM, Warnke RA. Immunosuppression- associated lymphoproliferative disorders in rheumatoid patients. Leuk Lymphoma 1995;16:363-368.
13. Sibilia J, Liote F, Mariette X. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Rev Rheum, Eng Ed 1998;65:267-273.
14. Chevrel G, Berger F, Miossec P, et al. Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1999;42:1773-1776.
15. Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999;26:1676-1680.
16. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991;18:1741-1743.
17. Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SMB. Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol 2002;118:567-568.
18. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:325-329.
19. Usman AR, Yunus MB. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate. J Rheumatol 1996;23:1095-1097.
20. Hoshida Y, Tomita Y, Zhiming D, et al. Lymphoproliferative disorders in autoimmune disease in Japan: Analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 2004;108:443-449.
21. van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamel OW. Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:638-642.
22. Kamel OW, van de Rijn, Le Brun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638-643.
23. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplant lymphoproliferative disorder: A review. Bone Marrow Transplant 2003;31:145-155.
24. Abed N, Casper JT, Camitta BM, et al. Post transplant lymphoproliferative disorder: Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. Bone Marrow Transplant 2004;33:321-327.
25. Heslop HE. Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas. Hematology 2005;1:260-266.
26. Macsween KF, Crawford DH. Epstein-Barr virus - Recent advances. Lancet Infect Dis 2003;3:131-140.
27. Rickinson AB, Kieff E. Epstein-Barr Virus. Field's Virology. Philaderphia. Lippincott Williams & Wilkins; 2001. pp 2575-2627.
28. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
29. Lymphoma Study Group of Japanese Pathologists. The WHO classification of malignant lymphomas in Japan. Incidence of recently recognized entities. Pathol Int 2000;50:696-702.
30. Glaser SL, Hsu JL. Hodgkin's disease in Asians: Incidence patterns and risk factors in population-based data. Leuk Res 2002;26:261-269.
31. Ogata M, Kikuchi H, Ono K, et al. Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia. Int J Hematol 2004;79:161-164.
32. Svensson AM, Jacobson ER, Ospina D, Tindle BH. Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low dose methotrexate: A case report and review of the literature. Int J Hematol 2006;83:47-50.
33. Feng W, Cohen JI, Fischer S, et al. Reactivation of latent Epstein-Barr virus by methotrexate: A potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 2004;96:1691-1702.
34. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and Genetics, Tumours of Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001.
35. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-1253.
36. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.